Advertisement

IRF2BPL mutation causes nigrostriatal degeneration presenting with dystonia, spasticity and keratoconus

      De novo mutations in the interferon regulatory factor 2 binding protein-like (IRF2BPL) gene have been recently associated with different neurological phenotypes [
      • Marcogliese P.C.
      • Shashi V.
      • Spillmann R.C.
      • Stong N.
      • Rosenfeld J.A.
      • Koenig M.K.
      • Martinez-Agosto J.A.
      • Herzog M.
      • Chen A.H.
      • Dickson P.I.
      • Lin H.J.
      • Vera M.U.
      • Salamon N.
      • Graham Jr., J.M.
      • Ortiz D.
      • Infante E.
      • Steyaert W.
      • Dermaut B.
      • Poppe B.
      • Chung H.L.
      • Zuo Z.
      • Lee P.T.
      • Kanca O.
      • Xia F.
      • Yang Y.
      • Smith E.C.
      • Jasien J.
      • Kansagra S.
      • Spiridigliozzi G.
      • El-Dairi M.
      • Lark R.
      • Riley K.
      • Koeberl D.D.
      • Golden-Grant K.
      • Program for Undiagnosed D.
      • Undiagnosed Diseases N.
      • Yamamoto S.
      • Wangler M.F.
      • Mirzaa G.
      • Hemelsoet D.
      • Lee B.
      • Nelson S.F.
      • Goldstein D.B.
      • Bellen H.J.
      • Pena L.D.M.
      IRF2BPL is associated with neurological phenotypes.
      ,
      • Tran Mau-Them F.
      • Guibaud L.
      • Duplomb L.
      • Keren B.
      • Lindstrom K.
      • Marey I.
      • Mochel F.
      • van den Boogaard M.J.
      • Oegema R.
      • Nava C.
      • Masurel A.
      • Jouan T.
      • Jansen F.E.
      • Au M.
      • Chen A.H.
      • Cho M.
      • Duffourd Y.
      • Lozier E.
      • Konovalov F.
      • Sharkov A.
      • Korostelev S.
      • Urteaga B.
      • Dickson P.
      • Vera M.
      • Martínez-Agosto J.A.
      • Begemann A.
      • Zweier M.
      • Schmitt-Mechelke T.
      • Rauch A.
      • Philippe C.
      • van Gassen K.
      • Nelson S.
      • Graham Jr., J.M.
      • Friedman J.
      • Faivre L.
      • Lin H.J.
      • Thauvin-Robinet C.
      • Vitobello A.
      De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
      ]. Clinical features include neurodevelopmental regression or speech and motor developmental delay, seizures, hypotonia, coordination difficulties, dystonia and pyramidal signs. So far, dopaminergic deficiency has not been described in IRF2BPL mutation carriers. We report a novel IRF2BPL mutation in a patient presenting with dystonia, spasticity and keratoconus, as well as pathologic dopamine transporter imaging.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marcogliese P.C.
        • Shashi V.
        • Spillmann R.C.
        • Stong N.
        • Rosenfeld J.A.
        • Koenig M.K.
        • Martinez-Agosto J.A.
        • Herzog M.
        • Chen A.H.
        • Dickson P.I.
        • Lin H.J.
        • Vera M.U.
        • Salamon N.
        • Graham Jr., J.M.
        • Ortiz D.
        • Infante E.
        • Steyaert W.
        • Dermaut B.
        • Poppe B.
        • Chung H.L.
        • Zuo Z.
        • Lee P.T.
        • Kanca O.
        • Xia F.
        • Yang Y.
        • Smith E.C.
        • Jasien J.
        • Kansagra S.
        • Spiridigliozzi G.
        • El-Dairi M.
        • Lark R.
        • Riley K.
        • Koeberl D.D.
        • Golden-Grant K.
        • Program for Undiagnosed D.
        • Undiagnosed Diseases N.
        • Yamamoto S.
        • Wangler M.F.
        • Mirzaa G.
        • Hemelsoet D.
        • Lee B.
        • Nelson S.F.
        • Goldstein D.B.
        • Bellen H.J.
        • Pena L.D.M.
        IRF2BPL is associated with neurological phenotypes.
        Am. J. Hum. Genet. 2018; 103: 245-260
        • Tran Mau-Them F.
        • Guibaud L.
        • Duplomb L.
        • Keren B.
        • Lindstrom K.
        • Marey I.
        • Mochel F.
        • van den Boogaard M.J.
        • Oegema R.
        • Nava C.
        • Masurel A.
        • Jouan T.
        • Jansen F.E.
        • Au M.
        • Chen A.H.
        • Cho M.
        • Duffourd Y.
        • Lozier E.
        • Konovalov F.
        • Sharkov A.
        • Korostelev S.
        • Urteaga B.
        • Dickson P.
        • Vera M.
        • Martínez-Agosto J.A.
        • Begemann A.
        • Zweier M.
        • Schmitt-Mechelke T.
        • Rauch A.
        • Philippe C.
        • van Gassen K.
        • Nelson S.
        • Graham Jr., J.M.
        • Friedman J.
        • Faivre L.
        • Lin H.J.
        • Thauvin-Robinet C.
        • Vitobello A.
        De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
        Genet. Med. 2019; 21: 1008-1014
        • Ganos C.
        • Zittel S.
        • Hidding U.
        • Funke C.
        • Biskup S.
        • Bhatia K.P.
        IRF2BPL mutations cause autosomal dominant dystonia with anarthria, slow saccades and seizures.
        Park. Relat. Disord. 2019; 68: 57-59
        • Skorvanek M.
        • Dusek P.
        • Rydzanicz M.
        • Walczak A.
        • Kosinska J.
        • Kostrzewa G.
        • Brzozowska M.
        • Han V.
        • Dosekova P.
        • Gdovinova Z.
        • Lehotska Z.
        • Lisowski P.
        • Ploski R.
        Neurodevelopmental disorder associated with IRF2BPL gene mutation: expanding the phenotype?.
        Park. Relat. Disord. 2019; 62: 239-241
        • Kiferle L.
        • Mazzucchi S.
        • Unti E.
        • Pesaresi I.
        • Fabbri S.
        • Nicoletti V.
        • Volterrani D.
        • Cosottini M.
        • Bonuccelli U.
        • Ceravolo R.
        Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study.
        Park. Relat. Disord. 2013; 19: 800-805